| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |